Atorvastatin + Ezetimibe

Therapeutic Segment

Generic Name

Indication

It is indicated as adjunctive therapy to diet for the reduction of elevated total-C, LDL-C, Apo B in patients with primary hypercholesterolemia and with HoFH as an adjunct to other lipid-lowering treatments or if such treatments are unavailable.

Brands

Form